Abstract:Background Spinal muscular atrophy (SMA) is an autosomal-recessive motor neuron disease leading to dysfunction of multiple organs. SMA can impair the quality of life (QoL) of patients and family. We aimed to evaluate the QoL of children with SMA and their caregivers and to identify the factors associated with QoL in a cross-sectional study conducted in China. Methods We recruited 101 children aged 0–17 years with SMA and their caregivers from a children’s hospital in China. Twenty-six children had type I SMA, 56 type II and 19 type III. Each child’s QoL was measured by the Pediatric Quality of Life Inventory 3.0 Neuromuscular Module (PedsQL NMM), which was completed by the child’s caregivers. The caregiver’s QoL was measured by the Pediatric Quality of Life Inventory Family Impact Module (PedsQL FIM). Information on sociodemographic characteristics, disease-specific characteristics, and treatments were collected using the proxy-reported questionnaire. Two-sample t tests and one-way ANOVA were used to compare differences in average scores of QoL across subgroups. Results Children with type III SMA had a higher average Total score of PedsQL NMM and higher average scores in domains Neuromuscular disease and Family resources than children with type I or type II SMA ( p < 0.001). Caregivers of children with type III SMA reported higher average scores in the domains of Physical, Emotional, Social, and Cognitive functioning of the PedsQL FIM than those of children with types I or II SMA ( p < 0.05). In addition, disease-related characteristics (e.g. limited mobility, stable course of disease, skeleton deformity, and digestive system dysfunction) and respiratory support were associated with lower average scores of PedsQL NMM and PedsQL FIM ( p < 0.05). Exercise training, multidisciplinary team management and use of the medication Nusinersen were each associated with higher average scores in both PedsQL NMM and FIM ( p < 0.05). Conclusion Our study has demonstrated factors that may impair or improve QoL of children patients with SMA and their parents. Particularly, QoL was relatively poor in children with type I and type II SMA as well as in their caregivers compared to those with type III SMA. We strongly recommend that standard of care in a multidisciplinary team be strengthened to improve the QoL of SMA patients. Our study called for increased attention from clinical physicians on measuring QoL in their clinical practices in order to enhance the understanding of impacts of SMA and to make better decisions regarding treatment.

Non-motor Symptoms and the Quality of Life in Multiple System Atrophy with Different Subtypes.

Non-motor symptoms in multiple system atrophy: A comparative study with Parkinson's disease and progressive supranuclear palsy

Health-related quality of life in patients with multiple system atrophy using the EQ-5D-5L

Health-Related Quality of Life in Multiple System Atrophy Using EQ-5D-5L: A Large Cross-Sectional Study in China

Sleep-related symptoms in multiple system atrophy: determinants and impact on disease severity

Clinical Characteristics and Quality of Life in Chinese Patients with Multiple System Atrophy.

Frontal Lobe Function, Behavioral Changes and Quality of Life in Patients with Multiple System Atrophy

Nonmotor Symptoms Are Independently Associated with Impaired Health‐related Quality of Life in Chinese Patients with Parkinson's Disease

Non-motor Symptoms in Chinese Parkinson's Disease Patients.

Depression and Anxiety in Multiple System Atrophy.

Quality of Life of Children with Spinal Muscular Atrophy and Their Caregivers from the Perspective of Caregivers: a Chinese Cross-Sectional Study

Longitudinal Evolution of Motor and Non-Motor Symptoms in Early-Stage Multiple System Atrophy: a 2-Year Prospective Cohort Study

Data-Driven Subtypes of Multiple System Atrophy and Their Implications for Prognosis

[Effects of Non-Motor Symptoms on Health-Related Quality of Life in Parkinson's Disease].

Clinical study on non-motor symptoms of Parkinson disease

Study of an Integrated Non-Motor Symptoms Questionnaire for Parkinson's Disease

Gender and Onset Age Related-Differences of Non-Motor Symptoms and Quality of Life in Drug-Naïve Parkinson's Disease.

In Vivo Cerebral Metabolic and Dopaminergic Characteristics in Multiple System Atrophy with Orthostatic Hypotension.

The Impact of Non-Motor Symptoms on the Health-Related Quality of Life of Parkinson'S Disease Patients from Southwest China

Non‐motor symptoms in early Parkinson's disease with different motor subtypes and their associations with quality of life

Characteristics of Nonmotor Symptoms in Progressive Supranuclear Palsy